Restart Life Sciences Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Cost of Revenue	-	-	-	-	0.01	Upgrade
Gross Profit	-	-	-	-	-0.01	Upgrade
Selling, General & Admin	0.86	0.59	0.86	1.4	1.58	Upgrade
Research & Development	0.01	0	0.07	0.12	0.86	Upgrade
Amortization of Goodwill & Intangibles	0	0	0	0	0	Upgrade
Operating Expenses	1.3	0.63	1.21	1.85	2.8	Upgrade
Operating Income	-1.3	-0.63	-1.21	-1.85	-2.8	Upgrade
Interest & Investment Income	-	-	-	0	0	Upgrade
Currency Exchange Gain (Loss)	-	0.01	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0.02	-0.03	-0.02	0.14	-0.04	Upgrade
EBT Excluding Unusual Items	-1.29	-0.65	-1.22	-1.71	-2.84	Upgrade
Gain (Loss) on Sale of Investments	-0.11	-0.14	-	-	0.02	Upgrade
Gain (Loss) on Sale of Assets	-	0.63	-	-	-	Upgrade
Other Unusual Items	-	0.38	-	-0.76	0.13	Upgrade
Pretax Income	-1.39	0.22	-1.22	-2.47	-2.68	Upgrade
Net Income	-1.39	0.22	-1.22	-2.47	-2.68	Upgrade
Net Income to Common	-1.39	0.22	-1.22	-2.47	-2.68	Upgrade
Shares Outstanding (Basic)	34	15	15	14	11	Upgrade
Shares Outstanding (Diluted)	34	16	15	14	11	Upgrade
Shares Change (YoY)	110.37%	9.79%	7.47%	22.91%	117.20%	Upgrade
EPS (Basic)	-0.04	0.01	-0.08	-0.18	-0.24	Upgrade
EPS (Diluted)	-0.04	0.01	-0.08	-0.18	-0.24	Upgrade
Free Cash Flow	-0.72	-0.07	-0.28	-2.41	-1.95	Upgrade
Free Cash Flow Per Share	-0.02	-0.00	-0.02	-0.18	-0.17	Upgrade
EBITDA	-1.3	-0.62	-1.2	-1.84	-2.8	Upgrade
D&A For EBITDA	0	0	0	0	0	Upgrade
EBIT	-1.3	-0.63	-1.21	-1.85	-2.8	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.